Prevention of intravenous drug incompatibilities in an intensive care unit

American Journal of Health-System Pharmacy

Volumn 65, Issue 19, 2008, Pages 1834-1840

  Bertsche, Thilo ^a   Mayer, Yvonne ^b   Stahl, Rebekka ^b   Hoppe Tichy, Torsten ^b   Encke, Jens ^b   Haefeli, Walter Emil ^b  

^a Clinical Cooperation Units Neurooncology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antiinfective agents; Drug administration; Errors, medication; Hospitals; Incompatibilities; Injections; Protocols; Stability

Indexed keywords

ACICLOVIR; AMINO ACID DERIVATIVE; AMINOPLASMAL; AMIODARONE; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZLOCILLIN; BIPERIDEN; CARBENICILLIN; CASPOFUNGIN; CATECHOLAMINE DERIVATIVE; CEFEPIME; CEFOTAXIME; CILASTATIN PLUS IMIPENEM; ELECTROLYTE; ERYTHROMYCIN; FUROSEMIDE; HEPARIN; HYDROCORTISONE; LINEZOLID; LORAZEPAM; MEZLOCILLIN; MITOMYCIN; NEOSTIGMINE; PANTOPRAZOLE; PHYTOMENADIONE; PIPERACILLIN PLUS TAZOBACTAM; STEROFUNDIN; TAZOBACTAM; THEOPHYLLINE; THIAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG INCOMPATIBILITY; DRUG INDICATION; DRUG INFUSION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; OUTCOME ASSESSMENT; PHARMACY STUDENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TOTAL PARENTERAL NUTRITION;

EID: 54749139300     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070633     Document Type: Article

References (35)

1. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997; 277:312-3.
2. Raupp P, Von Kries R, Schmidt E et al. Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies. Lancet. 1988; 1:700.
3. Sendo T, Hirakawa M, Makino K et al. Particulate contamination of lyophilized amphotericin B preparation during reconstitution process. J Clin Pharm Ther. 2001; 26:87-91.
4. Nichols RL, Smith JW. Bacterial contamination of an anesthetic agent. N Engl J Med. 1995; 333:184-5.
5. Nicholas E, Hess G, Colten HR. Degradation of penicillin, ticarcillin, and carbenicillin resulting from storage of unit doses. N Engl J Med. 1982; 306:547-8.
6. Taxis K, Barber N. Incidence and severity of intravenous drug errors in a German hospital. Eur J Clin Pharmacol. 2004; 59:815-7.
7. Chantelau E, Lange G, Gasthaus M et al. Interaction between plastic catheter tubings and regular insulin preparations used for continuous subcutaneous insulin-infusion therapy. Diabetes Care. 1987; 10:348-51.
8. Smith A, Bird G. The compatibility of diazepam with infusion fluids and their containers. J Clin Hosp Pharm. 1982; 7:181-6.
9. Vueba ML, Veiga F, Sousa JJ et al. Compatibility studies between Ibuprofen or ketoprofen with cellulose ether polymer mixtures using thermal analysis. Drug Dev Ind Pharm. 2005; 31:943-9.
10. Hutchison SM. Heparin and aminoglycosides instability. Drug Intell Clin Pharm. 1986; 20:886.
11. Rattenbury JM, Taylor CJ, Ganapathy S. Lipid deposition in parenteral infusion lines. Lancet. 1988; 1:701.
12. Halpern NA, Colucci RD, Alicea M et al. The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection. Int J Clin Pharmacol Ther Toxicol. 1989; 27:250-4.
13. Halpern NA, Colucci RD, Alicea M et al. Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection. Int J Clin Pharmacol Ther Toxicol. 1989; 27:294-7.
14. Jay GT, Fanikos J, Souney PF. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection. Am J Hosp Pharm. 1988; 45:1556-7.
15. Schaaf LJ, Tremel LC, Wulf BG et al. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside. J Clin Pharm Ther. 1990; 15:371-6.
16. Kähny-Simonius J. [Drug incompatibilities. Problems in the simultaneous administration of drugs in infusions.] Schweiz Rundsch Med Prax. 1993; 82:1320-7. In German.
17. Gikic M, Di Paolo ER, Pannatier A et al. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit. Pharm World Sci. 2000; 22:88-91.
18. Hopner JH, Schulte A, Thiessen J et al. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units.] Klin Pädiatr. 2007; 219:37-43. In German. [Erratum, Klin Pädiatr. 2007; 219:391.]
19. Zeller FP, Anders RJ. Compatibility of intravenous drugs in a coronary intensive care unit. Drug Intell Clin Pharm. 1986; 20:349-52.
20. Vogel Kahmann I, Bürki R, Denzler U et al. [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system." [Anaesthesist. 2003; 52:409-12. In German.
21. Vincent JL. Critical care nephrology: a multidisciplinary approach. Contrib Nephrol. 2007; 156:24-31.
22. Burdeu G, Crawford R, Van De Vreede M et al. Taking aim at infusion confusion. J Nurs Care Qual. 2006; 21:151-9.
23. Henderson JL, Polk RE, Kline BJ. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin. Am J Hosp Pharm. 1981; 38:1167-70.
24. Tyler LS, Rehder TL, Davis RB. Effect of gentamicin on heparin activity. Am J Hosp Pharm. 1981; 38:537-40.
25. Zaccardelli DS, Krcmarik CS, Wolk R et al. Stability of imipenem and cilastatin sodium in total parenteral nutrient solution. JPEN J Parenter Enteral Nutr. 1990; 14:306-9.
26. Bigley FP, Forsyth RJ, Henley MW. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions. Am J Hosp Pharm. 1986; 43:2803-9.
27. Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1994; 51:672-8.
28. Baririan N, Chanteux H, Viaene E et al. Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother. 2003; 51:651-8.
29. Thur MP, Miller WA, Latiolais CJ. Medication errors in a nurse-controlled parenteral admixture program. Am J Hosp Pharm. 1972; 29:298-304.
30. Schwartau NW, Schwerman EA Jr, Thompson CO et al. A comprehensive intravenous admixture system. Am J Hosp Pharm. 1973; 30:607-10.
31. Folli HL, Poole RL, Benitz WE et al. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987; 79:718-22.
32. Schneider MP, Cotting J, Pannatier A. Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci. 1998; 20:178-82.
33. Brodlie P, Henney C, Wood AJ. Problems of administering drugs by continuous infusion. Br Med J. 1974; 1:383-5.
34. Bates DW, Leape LL, Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998; 280:1311-6.
35. Bates DW, Teich JM, Lee J et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999; 6:313-21.